MENU
DYAI
AS OF
Feb 3 closing price
Price
$0.85
Change
-$0.28 (-24.78%)
Capitalization
30.76M
55 days until earnings call
Intraday BUY SELL Signals
+Compare
DYAI
Stock ticker: NASDAQ
AS OF
Feb 3 closing price
Price
$0.85
Change
-$0.28 (-24.78%)
Capitalization
30.76M

DYAI Dyadic International Forecast, Technical & Fundamental Analysis

Dyadic International Inc is a worldwide biotechnology platform company... Show more

Industry: #Biotechnology
DYAI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for DYAI with price predictions
Feb 02, 2026

DYAI's Stochastic Oscillator descends into oversold zone

The Stochastic Oscillator for DYAI moved into oversold territory on February 02, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DYAI advanced for three days, in of 217 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DYAI as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for DYAI turned negative on January 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

DYAI moved below its 50-day moving average on January 09, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DYAI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. DYAI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.792) is normal, around the industry mean (27.778). P/E Ratio (0.000) is within average values for comparable stocks, (51.342). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.892). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (15.504) is also within normal values, averaging (333.006).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DYAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
DYAI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

DYAI is expected to report earnings to fall 35.00% to -3 cents per share on March 31

Dyadic International DYAI Stock Earnings Reports
Q4'25
Est.
$-0.04
Q3'25
Missed
by $0.01
Q4'24
Missed
by $0.13
Q3'24
Beat
by $0.06
Q2'24
Est.
$-0.07
The last earnings report on November 12 showed earnings per share of -5 cents, missing the estimate of -5 cents. With 86.73K shares outstanding, the current market capitalization sits at 30.76M.
A.I. Advisor
published General Information

General Information

a researcher and manufacturer of genes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1044 North U.S. Highway One
Phone
+1 561 743-8333
Employees
7
Web
https://www.dyadic.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SBUX93.041.35
+1.47%
Starbucks Corp
PRLB53.670.22
+0.41%
Proto Labs
PC9.40N/A
N/A
Premium Catering Holdings Limited
BIPC48.74-0.07
-0.14%
Brookfield Infrastructure Corp
CEPO10.42-0.02
-0.19%
Cantor Equity Partners I Inc

DYAI and Stocks

Correlation & Price change

A.I.dvisor tells us that DYAI and MDGL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DYAI and MDGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYAI
1D Price
Change %
DYAI100%
-1.15%
MDGL - DYAI
29%
Poorly correlated
+0.09%
VRAX - DYAI
29%
Poorly correlated
-3.89%
FATE - DYAI
28%
Poorly correlated
+3.36%
TAOX - DYAI
27%
Poorly correlated
-3.28%
ROIV - DYAI
27%
Poorly correlated
+1.48%
More